基因组拉锯战可能促进癌症治疗
Some patients with myelodysplastic syndromes, like acute myeloid leukemia, benefit from a chemotherapy drug called decitabine that stunts cancer growth. But many others are resistant to decatibine's effects or become resistant over time. Wilmot Cancer In
阅读全文